JP2024522817A5 - - Google Patents

Info

Publication number
JP2024522817A5
JP2024522817A5 JP2023578136A JP2023578136A JP2024522817A5 JP 2024522817 A5 JP2024522817 A5 JP 2024522817A5 JP 2023578136 A JP2023578136 A JP 2023578136A JP 2023578136 A JP2023578136 A JP 2023578136A JP 2024522817 A5 JP2024522817 A5 JP 2024522817A5
Authority
JP
Japan
Prior art keywords
arylideneamino
nitrophenyl
pyrrole
pharmaceutically acceptable
solid oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023578136A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024522817A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/066906 external-priority patent/WO2022268825A1/en
Publication of JP2024522817A publication Critical patent/JP2024522817A/ja
Publication of JP2024522817A5 publication Critical patent/JP2024522817A5/ja
Pending legal-status Critical Current

Links

JP2023578136A 2021-06-21 2022-06-21 フェニルピロールアミノグアニジン塩及び製剤 Pending JP2024522817A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP21180708 2021-06-21
EP21180708.6 2021-06-21
EP21180702.9 2021-06-21
EP21180702 2021-06-21
EP21209855 2021-11-23
EP21209855.2 2021-11-23
PCT/EP2022/066906 WO2022268825A1 (en) 2021-06-21 2022-06-21 Phenyl pyrrole aminoguanidine salts and formulations

Publications (2)

Publication Number Publication Date
JP2024522817A JP2024522817A (ja) 2024-06-21
JP2024522817A5 true JP2024522817A5 (cg-RX-API-DMAC7.html) 2025-06-30

Family

ID=84544160

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023578136A Pending JP2024522817A (ja) 2021-06-21 2022-06-21 フェニルピロールアミノグアニジン塩及び製剤
JP2023578832A Pending JP2024523459A (ja) 2021-06-21 2022-06-21 フェニルピロールアミノグアニジンの塩及びフェニルピロールアミノグアニジウム塩の多形体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023578832A Pending JP2024523459A (ja) 2021-06-21 2022-06-21 フェニルピロールアミノグアニジンの塩及びフェニルピロールアミノグアニジウム塩の多形体

Country Status (11)

Country Link
US (3) US12661336B2 (cg-RX-API-DMAC7.html)
EP (3) EP4359383A1 (cg-RX-API-DMAC7.html)
JP (2) JP2024522817A (cg-RX-API-DMAC7.html)
KR (2) KR20240024818A (cg-RX-API-DMAC7.html)
AU (2) AU2022296767A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023026909A2 (cg-RX-API-DMAC7.html)
CA (2) CA3220756A1 (cg-RX-API-DMAC7.html)
ES (1) ES3045575T3 (cg-RX-API-DMAC7.html)
IL (2) IL309102A (cg-RX-API-DMAC7.html)
MX (2) MX2023014174A (cg-RX-API-DMAC7.html)
WO (2) WO2022268825A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3175172A1 (en) * 2020-03-31 2021-10-07 Synact Pharma Aps Treatment of symptomatic viral diseases
IL309102A (en) * 2021-06-21 2024-02-01 Synact Pharma Aps Salts and formulations of phenyl pyrrole aminoguanidine
EP4522160A1 (en) * 2022-05-12 2025-03-19 SynAct Pharma ApS Resomelagon and its derivatives for the treatment of cardiovascular disease, hypertension and atherosclerosis
EP4637921A1 (en) * 2022-12-21 2025-10-29 SynAct Pharma ApS Polymorph of phenyl pyrrole hydrazine carboximidamide compound
AU2024398488A1 (en) 2023-12-11 2026-06-04 Synact Pharma Aps Treatment of subpopulation of patients with rheumatoid arthritis

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9604348D0 (sv) 1996-11-26 1996-11-26 Wapharm Ab Användning av hydroxyguanidiner
AU7464998A (en) 1997-10-27 1999-05-17 Trega Biosciences, Inc. Melanocortin receptor ligands and methods of using same
US6127381A (en) 1998-04-28 2000-10-03 Basu; Amaresh Isoquinoline compound melanocortin receptor ligands and methods of using same
AU742425B2 (en) 1998-06-11 2002-01-03 Merck & Co., Inc. Spiropiperidine derivatives as melanocortin receptor agonists
HK1044954B (en) 1999-03-29 2008-11-21 The Procter & Gamble Company Melanocortin receptor ligands
WO2000074679A1 (en) 1999-06-04 2000-12-14 Merck & Co., Inc. Substituted piperidines as melanocortin-4 receptor agonists
AU6605800A (en) 1999-07-16 2001-02-05 Trega Biosciences, Inc. Melanocortin receptor-3 ligands to treat sexual dysfunction
US6632815B2 (en) 1999-09-17 2003-10-14 Millennium Pharmaceuticals, Inc. Inhibitors of factor Xa
AU781880B2 (en) 1999-09-17 2005-06-16 Millennium Pharmaceuticals, Inc. Inhibitors of factor Xa
US6844367B1 (en) 1999-09-17 2005-01-18 Millennium Pharmaceuticals, Inc. Benzamides and related inhibitors of factor Xa
US6720317B1 (en) 1999-09-17 2004-04-13 Millennium Pharmaceuticals, Inc. Inhibitors of factor Xa
CZ2002961A3 (cs) 1999-09-17 2002-08-14 Millennium Pharmaceuticals, Inc. Benzamidy a příbuzné sloučeniny pro inhibici faktoru Xa
AU2001228681A1 (en) 2000-01-28 2001-08-07 Melacure Therapeutics Ab Novel aromatic amines and amides acting on the melanocortin receptors
WO2001055106A2 (en) 2000-01-28 2001-08-02 Melacure Therapeutics Ab Novel melanocortin receptor agonists and antagonists
GB0002059D0 (en) 2000-01-28 2000-03-22 Melacure Therapeutics Ab Novel aromatic amines
KR100440370B1 (ko) 2000-04-01 2004-07-19 (주)명문엘씨 2중 사출에 의한 밀폐용기 뚜껑
GB0019357D0 (en) 2000-08-07 2000-09-27 Melacure Therapeutics Ab Novel phenyl guanidines
US6768024B1 (en) 2000-08-04 2004-07-27 Lion Bioscience Ag Triamine derivative melanocortin receptor ligands and methods of using same
GB0019359D0 (en) 2000-08-07 2000-09-27 Melacure Therapeutics Ab Novel guanidines
DZ3415A1 (fr) 2000-08-31 2002-03-07 Chiron Corp Guanidinobenzamides comme mc4-r agonistes.
US20030069169A1 (en) 2001-03-02 2003-04-10 Macor John E. Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-AMP associated disorders
GB0119172D0 (en) 2001-08-06 2001-09-26 Melacure Therapeutics Ab Phenyl pyrrole derivatives
CA2363528A1 (en) 2001-11-19 2003-05-19 Merck Patent Gesellschaft Mit Beschraenkter Haftung Immediate release tablet containing naproxen sodium
GB2398299A (en) 2003-02-13 2004-08-18 Melacure Therapeutics Ab Pharmaceutically active phenyl-pyrrole derivatives
MY149159A (en) 2005-11-15 2013-07-31 Hoffmann La Roche Method for treating joint damage
SI2348016T1 (sl) 2006-06-09 2016-10-28 Synact Pharma Aps Derivati fenil pirol aminogvanidina
GB0624987D0 (en) 2006-12-14 2007-01-24 Acure Pharma Ab Novel aminoguanidines as melanocortin receptor ligands
EP2045250A1 (en) 2007-09-26 2009-04-08 Action Pharma A/S Ring-substituted phenyl pyrrole aminoguanidine derivatives
WO2009071101A1 (en) 2007-12-07 2009-06-11 Action Pharma A/S N-modified aminoguanidine derivatives
WO2009074157A1 (en) 2007-12-13 2009-06-18 Action Pharma A/S Fully-modified phenyl pyrrole aminoguanidines
US10387927B2 (en) 2010-01-15 2019-08-20 Dell Products L.P. System and method for entitling digital assets
EA201290860A1 (ru) 2010-03-03 2013-04-30 Тева Фармасьютикал Индастриз Лтд. Лечение ревматоидного артрита комбинацией лаквинимода и метотрексата
JP2011190199A (ja) 2010-03-12 2011-09-29 Hideto Nakamura 関節リウマチ薬
US9662807B2 (en) 2011-12-21 2017-05-30 GKN Aerospace Services Structures, Corp. Method for forming a fabric preform for a composite material by separately tensioning tows
WO2014060606A1 (en) 2012-10-19 2014-04-24 Txp Pharma Gmbh Alpha- and gamma-msh analogues
US9917808B2 (en) 2013-03-14 2018-03-13 International Business Machines Corporation Grouping electronic messages
WO2015162483A1 (en) 2014-04-22 2015-10-29 Txp Pharma Gmbh Alpha- and gamma-msh analogues
WO2015162486A1 (en) 2014-04-22 2015-10-29 Txp Pharma Gmbh Linear gamma msh with c- and / or n-terminal extensions of lysine and / or glutamic acid residues
WO2017141343A1 (ja) 2016-02-16 2017-08-24 三菱電機株式会社 圧縮機
ES2899200T3 (es) 2018-06-22 2022-03-10 Synact Pharma Aps Tratamiento de proteinuria
WO2020107221A1 (en) 2018-11-27 2020-06-04 Tsinghua University Chemical activators of nicotinamide mononucleotide adenlyly transferase 2 (nmnat2) and uses thereof
HUE059638T2 (hu) * 2019-05-10 2022-12-28 Synact Pharma Aps Ízületi gyulladásos betegségek kombinált kezelése
CA3175172A1 (en) * 2020-03-31 2021-10-07 Synact Pharma Aps Treatment of symptomatic viral diseases
CN113730797B (zh) 2020-05-29 2023-05-16 创领心律管理医疗器械(上海)有限公司 电极板及可穿戴式除颤设备
IL309102A (en) * 2021-06-21 2024-02-01 Synact Pharma Aps Salts and formulations of phenyl pyrrole aminoguanidine

Similar Documents

Publication Publication Date Title
JPWO2023027198A5 (cg-RX-API-DMAC7.html)
JP2025142338A5 (cg-RX-API-DMAC7.html)
US4248858A (en) Sustained release pharmaceutical compositions
JP2022546471A5 (cg-RX-API-DMAC7.html)
US20080027032A1 (en) Combinations comprising cox-2 inhibitors and aspirin
JP2005525369A5 (cg-RX-API-DMAC7.html)
TW200304832A (en) Palatable oral suspension and method
EP4359076B1 (en) Phenyl pyrrole aminoguanidine salts and formulations
JP2022533368A5 (cg-RX-API-DMAC7.html)
JP2020510660A5 (cg-RX-API-DMAC7.html)
JP2024502446A5 (cg-RX-API-DMAC7.html)
JP2023529011A (ja) インデン化合物、その医薬組成物、及びそれらの治療応用
US20260137638A1 (en) Stat3 inhibitors for use in the treatment of non-viral liver cancer
US20050203115A1 (en) Narcotic-NSAID ion pairs
JP2025509278A5 (cg-RX-API-DMAC7.html)
JP4608093B2 (ja) 組合せ製剤としてのエンドセリン拮抗剤およびβ−受容体ブロッカー
CN107018650B (zh) 包含氨氯地平和氯沙坦的固体药物组合物
JP2025517683A5 (cg-RX-API-DMAC7.html)
JP2665357B2 (ja) 心不全治療用医薬組成物
JP2011246497A (ja) イオン交換樹脂を使用する経口キノロン液状製剤の味覚マスキング
JP2024540673A5 (cg-RX-API-DMAC7.html)
CN121057592A (zh) Psma靶向放射性药物和dna损伤应答抑制剂联合疗法
JPS5970611A (ja) 医薬組成物
JP2022541482A (ja) ベリヌラドを含む用量ダンピング耐性医薬組成物
BR122025026872A2 (pt) Forma de dosagem sólida oral de liberação imediata e seu uso